XLV (Health Care Select) Stock Analysis - News

Health Care Select (XLV) is a publicly traded Financial Services sector company. As of May 21, 2026, XLV trades at $147.20 with a market cap of $0 and a P/E ratio of 0.00. XLV moved -0.14% today. Year to date, XLV is -5.10%; over the trailing twelve months it is +9.23%. Its 52-week range spans $127.35 to $160.59. Rallies surfaces XLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in XLV news today?

XLV holds flat as UNH/CVS earnings read-through offsets big-pharma drift: XLV is flat on May 7, 2026 as gains in managed care and select services are being offset by softness in mega-cap pharma, leaving the health-care sector near unchanged. The clearest current drivers are post-earnings read-through from major constituents (notably UnitedHealth and CVS) and the ongoing policy backdrop on prior-authorization/interoperability that matters most for insurers and PBMs.

XLV Key Metrics

Key financial metrics for XLV
MetricValue
Price$147.20
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.59%
52-Week High$160.59
52-Week Low$127.35
Volume10.30M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest XLV News

XLV Analyst Consensus

XLV analyst coverage data. Average price target: $0.00.

Common questions about XLV

What changed in XLV news today?
XLV holds flat as UNH/CVS earnings read-through offsets big-pharma drift: XLV is flat on May 7, 2026 as gains in managed care and select services are being offset by softness in mega-cap pharma, leaving the health-care sector near unchanged. The clearest current drivers are post-earnings read-through from major constituents (notably UnitedHealth and CVS) and the ongoing policy backdrop on prior-authorization/interoperability that matters most for insurers and PBMs.
Does Rallies summarize XLV news?
Yes. Rallies summarizes XLV news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is XLV research on Rallies investment advice?
No. Rallies provides research, data, and educational context for XLV. It does not provide personalized investment advice.
XLV

Health Care Select